Home / Montelukast / Czechia
CZ ATC R03DC03 · updated 2 Nov 2026
Montelukast shortage in Czechia
Is there a Montelukast shortage in Czechia?
Yes. As of 2 Nov 2026, 7 Montelukast products are reported short in Czechia, the first since 1 Jun 2025. The company estimate for the return is 30 Nov 2026 (latest 30 Nov 2027). Main reason: manufacturing problem.
Also short in United States, Canada, France, Italy, Spain, Ireland, Austria, Belgium, Norway, Sweden, Japan, New Zealand. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | MONTELUKAST MYLAN 5MG 5MG TBL MND 30 | VIATRIS LIMITED, Dublin | 1 Jun 2025 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | MONTELUKAST MYLAN 5MG 5MG TBL MND 100 | VIATRIS LIMITED, Dublin | 20 Jul 2025 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | MONTELUKAST MEDREG 10MG 10MG TBL FLM 98 | MEDREG s.r.o., Praha | 17 Aug 2026 | 30 Nov 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MONTELUKAST TEVA 5MG 5MG TBL MND 28 | Teva Pharmaceuticals CR, s.r.o., Praha | 18 Sep 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | MONTELUKAST TEVA 5MG 5MG TBL MND 98 | Teva Pharmaceuticals CR, s.r.o., Praha | 26 Oct 2026 | 31 Dec 2026 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | CASTISPIR 10MG 10MG TBL FLM 98 | Sandoz s.r.o., Praha | 29 Oct 2026 | 15 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | MONTELUKAST TEVA 4MG 4MG TBL MND 28 | Teva Pharmaceuticals CR, s.r.o., Praha | 30 Oct 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.